NCT07386028 Full Sternotomy vs Mini-sternotomy for Ascending Aortic Pathology
| NCT ID | NCT07386028 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tomsk Cardiology Research Institute |
| Condition | Ascending Aortic Aneurysm |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-07-10 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-07-10 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates outcomes after hemiarch repair in patients with chronic ascending aortic disease. The patients will be divided into two groups according to surgical approach: 100 patients will undergo hemiarch repair via full sternotomy (FS group) and 100 patients will receive hemiarch repair via J-shaped mini-sternotomy (MS group). Early and late outcomes will be recorded.
Eligibility Criteria
Inclusion Criteria: * Signed informed consent. * Ascending aorta greater than 5 cm without involving the aortic arch Exclusion Criteria: * Acute aortic dissection or urgent/emergent cases. * Redo aortic surgery. * Aortic arch surgery. * Concomitant CABG or left ventricle restoration
Contact & Investigator
Boris N. Kozlov, MD, PhD
PRINCIPAL INVESTIGATOR
Cardiology Research Institute, Tomsk National Research Medical Center
Frequently Asked Questions
Who can join the NCT07386028 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Ascending Aortic Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07386028 currently recruiting?
Yes, NCT07386028 is actively recruiting participants. Contact the research team at pand2006@yandex.ru for enrollment information.
Where is the NCT07386028 trial being conducted?
This trial is being conducted at Tomsk, Russia.
Who is sponsoring the NCT07386028 clinical trial?
NCT07386028 is sponsored by Tomsk Cardiology Research Institute. The principal investigator is Boris N. Kozlov, MD, PhD at Cardiology Research Institute, Tomsk National Research Medical Center. The trial plans to enroll 200 participants.